Statement of Principles concerning methaemoglobinaemia (Reasonable Hypothesis) (No. 17 of 2019)

Administered by Department of Veterans' Affairs

Legislation au F2019L00222 In force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

 

STATEMENT OF PRINCIPLES CONCERNING

METHAEMOGLOBINAEMIA

(REASONABLE HYPOTHESIS) (NO. 17 OF 2019)

 

VETERANS' ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

  1. This is the Explanatory Statement to the Statement of Principles concerning methaemoglobinaemia (Reasonable Hypothesis) (No. 17 of 2019).

Background

2.             The Repatriation Medical Authority (the Authority), under subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA), repeals Instrument No. 47 of 2010 (Federal Register of Legislation No. F2010L01660) determined under subsection 196B(2) of the VEA concerning methaemoglobinaemia.

3.             The Authority is of the view that there is sound medical-scientific evidence that indicates that methaemoglobinaemia and death from methaemoglobinaemia can be related to particular kinds of service.  The Authority has therefore determined pursuant to subsection 196B(2) of the VEA a Statement of Principles concerning methaemoglobinaemia (Reasonable Hypothesis) (No. 17 of 2019).  This Instrument will in effect replace the repealed Statement of Principles.

Purpose and Operation

4.             The Statement of Principles will be applied in determining claims under the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).

5.             The Statement of Principles sets out the factors that must as a minimum exist, and which of those factors must be related to the following kinds of service rendered by a person:

 operational service under the VEA;

 peacekeeping service under the VEA;

 hazardous service under the VEA;

 British nuclear test defence service under the VEA;

 warlike service under the MRCA;

 non-warlike service under the MRCA,

before it can be said that a reasonable hypothesis has been raised connecting methaemoglobinaemia or death from methaemoglobinaemia, with the circumstances of that service.  The Statement of Principles has been determined for the purposes of both the VEA and the MRCA.

6.             This Instrument results from an investigation notified by the Authority in the Government Notices Gazette of 14 November 2017 concerning methaemoglobinaemia in accordance with section 196G of the VEA.  The investigation involved an examination of the sound medical-scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered.

7.             The contents of this Instrument are in similar terms as the repealed Instrument.  Comparing this Instrument and the repealed Instrument, the differences include:

  • adopting the latest revised Instrument format, which commenced in 2015;
  • specifying a day of commencement for the Instrument in section 2;
  • revising the definition of 'methaemoglobinaemia' in subsection 7(2);
  • revising the ICD-10-AM code for 'methaemoglobinaemia' in subsection 7(3);
  • revising the reference to 'ICD-10-AM code' in subsection 7(4);
  • revising the factors in subsections 9(1) & 9(5) concerning 'a drug that causes oxidation of haemoglobin', by the inclusion of a note;
  • revising the factors in subsections 9(2) & 9(6) concerning 'a chemical agent that causes oxidation of haemoglobin', by the inclusion of a note;
  • new definitions of 'MRCA' and 'VEA' in Schedule 1 - Dictionary; and
  • revising the definition of 'relevant service' in Schedule 1 Dictionary.

Consultation

8.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to methaemoglobinaemia in the Government Notices Gazette of 14 November 2017, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, the Military Rehabilitation and Compensation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  No submissions were received for consideration by the Authority during the investigation.

Human Rights

9.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.  A Statement of Compatibility with Human Rights follows.

Finalisation of Investigation

10.         The determining of this Instrument finalises the investigation in relation to methaemoglobinaemia as advertised in the Government Notices Gazette of 14 November 2017.

References

11.         A list of references relating to the above condition is available to any person or organisation referred to in subsection 196E(1)(a) to (c) of the VEA.  Any such request must be made in writing to the Repatriation Medical Authority at the following address:

The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001

Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Statement of Principles No. 17 of 2019

Kind of Injury, Disease or Death: Methaemoglobinaemia

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).  Part XIA of the VEA requires the determination of these instruments outlining the factors linking particular kinds of injury, disease or death with service such being determined solely on the available sound medical-scientific evidence.

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have methaemoglobinaemia;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • outlines the factors which the current sound medical-scientific evidence indicates must as a minimum exist, before it can be said that a reasonable hypothesis has been raised, connecting methaemoglobinaemia with the circumstances of eligible service rendered by a person, as set out in clause 5 of the Explanatory Statement;
  • replaces Instrument No. 47 of 2010; and
  • reflects developments in the available sound medical-scientific evidence concerning methaemoglobinaemia which have occurred since that earlier instrument was determined. 

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICSECR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICSECR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members;
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD); and
  • ensuring that those rights "will be exercised without discrimination of any kind as to race, colour, sex, language, religion, political or other opinion, national or social origin, property, birth or other status" (Art 2, ICESCR).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Statement of Principles concerning methaemoglobinaemia (Reasonable Hypothesis) (No. 17 of 2019) was enacted to address the gap in the medical-scientific evidence concerning the relationship between methaemoglobinaemia and certain kinds of military service. This instrument, determined by the Repatriation Medical Authority under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004, sets out the factors that must exist for a reasonable hypothesis to connect methaemoglobinaemia or death from methaemoglobinaemia with specific service circumstances, including operational, peacekeeping, hazardous, and British nuclear test defence service under the VEA, as well as warlike and non-warlike service under the MRCA. This legislative instrument facilitates the assessment and determination of compensation and benefits for eligible persons by clarifying the qualifying conditions and ensuring they are reasonable, proportionate, and transparent, thereby promoting various human rights such as the right to social security and the right to the highest attainable standard of physical and mental health. It replaces the earlier Instrument No. 47 of 2010 and reflects recent developments in the medical-scientific evidence concerning methaemoglobinaemia.

Scope and Application

The Statement of Principles concerning methaemoglobinaemia (Reasonable Hypothesis) (No. 17 of 2019) applies to veterans and current or former Defence Force members who are making or have made claims under the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA). This instrument identifies the circumstances in which methaemoglobinaemia may be connected to specific types of service, thereby qualifying individuals for medical treatment and compensation. The Statement of Principles sets out the minimum factors that must exist and be related to certain kinds of service, such as operational, peacekeeping, hazardous, and British nuclear test defence service, before a reasonable hypothesis can be raised that links methaemoglobinaemia or death from methaemoglobinaemia with the service. This instrument replaces the previous Statement of Principles No. 47 of 2010, reflecting updated medical-scientific evidence. The application of this Act is determined at the Commonwealth level under the VEA and MRCA, and it facilitates claims processing, assessment, and review by relevant authorities. The instrument is compatible with human rights, promoting rights to social security, adequate living standards, health, and non-discrimination.

Key Provisions

The Statement of Principles concerning methaemoglobinaemia (Reasonable Hypothesis) (No. 17 of 2019) outlines the specific circumstances under which methaemoglobinaemia and death from methaemoglobinaemia can be reasonably hypothesised to be related to certain types of service. According to section 5 of the Explanatory Statement, these types of service include operational service, peacekeeping service, hazardous service, British nuclear test defence service under the Veterans' Entitlements Act 1986 (VEA), and warlike or non-warlike service under the Military Rehabilitation and Compensation Act 2004 (MRCA). The Statement of Principles serves to facilitate the assessment and review of claims related to these conditions by providing clear guidelines for determining eligibility for medical treatment and compensation. This legislative instrument is determined under subsection 196B(2) of the VEA and replaces Instrument No. 47 of 2010, reflecting updated medical-scientific evidence. The Statement of Principles imposes several obligations on parties involved in the claims process. Claimants must provide evidence linking their methaemoglobinaemia to their service under the specified categories, as outlined in section 5. The Repatriation Commission and the Military Rehabilitation and Compensation Commission must assess these claims in accordance with the principles set forth, ensuring that the evaluation is based on sound medical-scientific evidence. Additionally, the Veterans' Review Board and the Administrative Appeals Tribunal are tasked with reviewing decisions made by the Repatriation Commission and the Military Rehabilitation and Compensation Commission, respectively, to ensure compliance with the Statement of Principles. Violations of the provisions outlined in the Statement of Principles concerning methaemoglobinaemia can lead to various civil and criminal consequences. For example, providing false information in a claim or obstructing the claims process could result in civil penalties, including fines. While the Statement of Principles itself does not specify criminal penalties, any fraudulent activities related to the claims process could potentially lead to criminal charges under other relevant legislation. The specific penalties would depend on the nature and severity of the breach, as well as the applicable laws governing such conduct. The Statement of Principles ensures that the rights of veterans, current and former Defence Force members, and their dependents are upheld by facilitating the assessment and determination of claims related to methaemoglobinaemia. This includes the right to social security, an adequate standard of living, and the highest attainable standard of physical and mental health, as outlined in various international human rights instruments. By providing a clear framework for determining eligibility for benefits, the Statement of Principles promotes transparency and accessibility in the claims process, thereby protecting the rights of those affected by methaemoglobinaemia.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Statutory Instrument
Concepts
Definitions & Interpretation
Regulatory Standards
Compliance Obligations

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.